1228 related articles for article (PubMed ID: 8877711)
41. Detection of tumor contamination of peripheral stem cells in patients with lymphoma using cell culture and polymerase chain reaction technology.
Chan WC; Wu GQ; Greiner TC; Vose JM; Sharp JG
J Hematother; 1994; 3(3):175-84. PubMed ID: 7827867
[TBL] [Abstract][Full Text] [Related]
42. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
43. Detection of disseminated tumor cells: strategies and diagnostic implications.
Zehentner BK
Expert Rev Mol Diagn; 2002 Jan; 2(1):41-8. PubMed ID: 11963801
[TBL] [Abstract][Full Text] [Related]
44. [Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors].
Hinterberger W; Buxhofer V; Ogris E; Zelenka P; Kier P; Ruckser R; Dorner S; Habertheuer KH; Vedovelli H; Schindler S; Hinterberger-Fischer M
Acta Med Austriaca Suppl; 2002; 59():2-8. PubMed ID: 12506753
[TBL] [Abstract][Full Text] [Related]
45. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
46. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
47. What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
Quaglino P; Osella-Abate S; Savoia P; Bernengo MG; Cappello N; Cavallo F
J Clin Oncol; 2007 Mar; 25(9):1140-1; author reply 1141-2. PubMed ID: 17369579
[No Abstract] [Full Text] [Related]
48. Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN.
Chaubal S; Wollenberg B; Kastenbauer E; Zeidler R
Anticancer Res; 1999; 19(3B):2237-42. PubMed ID: 10472336
[TBL] [Abstract][Full Text] [Related]
49. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
51. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease.
Mori M; Mimori K; Ueo H; Karimine N; Barnard GF; Sugimachi K; Akiyoshi T
Int J Cancer; 1996 Dec; 68(6):739-43. PubMed ID: 8980176
[TBL] [Abstract][Full Text] [Related]
52. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique.
Ren J; Chen Z; Juan SJ; Yong XY; Pan BR; Fan DM
Cancer; 2000 Jan; 88(2):280-5. PubMed ID: 10640958
[TBL] [Abstract][Full Text] [Related]
53. Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.
Rappl G; Hasselmann DO; Rössler M; Ugurel S; Tilgen W; Reinhold U
Ann N Y Acad Sci; 2001 Sep; 945():189-91. PubMed ID: 11708477
[TBL] [Abstract][Full Text] [Related]
54. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
Seiden M; Sklar JL
Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
[No Abstract] [Full Text] [Related]
55. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.
Klein CA; Blankenstein TJ; Schmidt-Kittler O; Petronio M; Polzer B; Stoecklein NH; Riethmüller G
Lancet; 2002 Aug; 360(9334):683-9. PubMed ID: 12241875
[TBL] [Abstract][Full Text] [Related]
56. Review: polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate, and thyroid carcinomas.
Ghossein RA; Carusone L; Bhattacharya S
Diagn Mol Pathol; 1999 Dec; 8(4):165-75. PubMed ID: 10617272
[TBL] [Abstract][Full Text] [Related]
57. Detection of residual disease in acute leukemia using immunological markers.
Ryan DH; van Dongen JJ
Cancer Treat Res; 1988; 38():173-207. PubMed ID: 2908595
[No Abstract] [Full Text] [Related]
58. [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].
Gretschel S; Bembenek A; Schulze T; Kemmner W; Schlag PM
Chirurg; 2006 Dec; 77(12):1104-17. PubMed ID: 17119886
[TBL] [Abstract][Full Text] [Related]
59. Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients.
Molnar B; Sipos F; Galamb O; Tulassay Z
Dig Dis; 2003; 21(4):320-5. PubMed ID: 14752222
[TBL] [Abstract][Full Text] [Related]
60. Molecular tools in the detection of micrometastatic cancer cells--technical aspects and clinical relevance.
von Knebel Doeberitz M; Weitz J; Koch M; Lacroix J; Schrödel A; Herfarth C
Recent Results Cancer Res; 2001; 158():181-6. PubMed ID: 11092045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
